327 related articles for article (PubMed ID: 22906356)
1. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.
Iorio R; Fryer JP; Hinson SR; Fallier-Becker P; Wolburg H; Pittock SJ; Lennon VA
J Autoimmun; 2013 Feb; 40():21-7. PubMed ID: 22906356
[TBL] [Abstract][Full Text] [Related]
2. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
[TBL] [Abstract][Full Text] [Related]
3. Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays.
Crane JM; Lam C; Rossi A; Gupta T; Bennett JL; Verkman AS
J Biol Chem; 2011 May; 286(18):16516-24. PubMed ID: 21454592
[TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Rossi A; Ratelade J; Papadopoulos MC; Bennett JL; Verkman AS
Glia; 2012 Dec; 60(12):2027-39. PubMed ID: 22987455
[TBL] [Abstract][Full Text] [Related]
5. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
[TBL] [Abstract][Full Text] [Related]
6. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.
Hinson SR; Romero MF; Popescu BF; Lucchinetti CF; Fryer JP; Wolburg H; Fallier-Becker P; Noell S; Lennon VA
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1245-50. PubMed ID: 22128336
[TBL] [Abstract][Full Text] [Related]
7. Optic neuritis in neuromyelitis optica.
Levin MH; Bennett JL; Verkman AS
Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
[TBL] [Abstract][Full Text] [Related]
8. Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.
Soltys J; Liu Y; Ritchie A; Wemlinger S; Schaller K; Schumann H; Owens GP; Bennett JL
J Clin Invest; 2019 Apr; 129(5):2000-2013. PubMed ID: 30958797
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: A Target of Autoimmunity in the Central Nervous System.
Abe Y; Yasui M
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454180
[TBL] [Abstract][Full Text] [Related]
10. Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding.
Pisani F; Mastrototaro M; Rossi A; Nicchia GP; Tortorella C; Ruggieri M; Trojano M; Frigeri A; Svelto M
J Biol Chem; 2011 Mar; 286(11):9216-24. PubMed ID: 21212277
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica pathogenesis and aquaporin 4.
Graber DJ; Levy M; Kerr D; Wade WF
J Neuroinflammation; 2008 May; 5():22. PubMed ID: 18510734
[TBL] [Abstract][Full Text] [Related]
12. Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity.
Pisani F; Sparaneo A; Tortorella C; Ruggieri M; Trojano M; Mola MG; Nicchia GP; Frigeri A; Svelto M
PLoS One; 2013; 8(11):e79185. PubMed ID: 24260168
[TBL] [Abstract][Full Text] [Related]
13. Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays.
Phuan PW; Ratelade J; Rossi A; Tradtrantip L; Verkman AS
J Biol Chem; 2012 Apr; 287(17):13829-39. PubMed ID: 22393049
[TBL] [Abstract][Full Text] [Related]
14. Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.
Verkman AS; Phuan PW; Asavapanumas N; Tradtrantip L
Brain Pathol; 2013 Nov; 23(6):684-95. PubMed ID: 24118484
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
[TBL] [Abstract][Full Text] [Related]
16. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG.
Owens GP; Ritchie A; Rossi A; Schaller K; Wemlinger S; Schumann H; Shearer A; Verkman AS; Bennett JL
J Biol Chem; 2015 May; 290(19):12123-34. PubMed ID: 25792738
[TBL] [Abstract][Full Text] [Related]
18. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
[TBL] [Abstract][Full Text] [Related]
19. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Tuller F; Holzer H; Schanda K; Aboulenein-Djamshidian F; Höftberger R; Khalil M; Seifert-Held T; Leutmezer F; Berger T; Reindl M
J Neuroinflammation; 2016 Jul; 13(1):176. PubMed ID: 27371173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
